跳至主要内容
临床试验/NCT01890278
NCT01890278Unknown不适用

Randomized Phase II Trial of Conventional vs IMRT Whole Brain Radiotherapy for Brain Metastases

Good Samaritan Hospital Medical Center, New York2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2013年6月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
2
主要终点
Alopecia

研究概览

简要总结

In this study the patient will receive either whole brain radiation therapy given by intensity modulated radiation therapy (IMRT) or standard conventional radiation. In IMRT therapy radiation dose to the parts of the brain that do not contain tumors is reduced. This study will look to see if this approach results in less hair loss or fewer memory Problems, as compared to the standard technique. The study will also look at the effectiveness of both techniques in controlling the growth of the tumor.

详细描述

SCHEMA For Patients with MRI Evidence of Brain Metastasis within 1 Month Prior to Registration

Prior to Treatment Start Confirmation of patient's insurance coverage prior to receiving study-related procedures to e ensure that treatment with IMRT will not be denied.

Radiation Therapy

  1. MRI with Fused CT Simulation
  2. Neurocognitive Function Testing
  3. Quality of Life Assessment

Arm 1 Whole brain radiation therapy delivered via IMRT (37.5 Gy to the brain tumors, 30 Gy to the uninvolved brain in 15 fractions), mean dose of less than 18 Gy to the scalp

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ELIGIBILITY CHECKLIST
  • Inclusion Criteria:
  • Evidence of at least one brain metastasis on a gadolinium contrast-enhanced MRI
  • Pathologic/histological/cytologic proof of a diagnosis of a non-hematopoietic malignancy within 5 years of study entry.
  • Patient ≥18 years of age?
  • Fall into RTOG Recursive Partition Analysis (RPA) class I or II.
  • Karnofsky Performance Score ≥
  • (See Appendix III)
  • Biopsy done at least 1 week prior to registration. (This requirement does not apply to stereotactic biopsies.)

排除标准

  • Contraindication to MR imaging such as implanted metal devices or foreign bodies, severe claustrophobia.
  • Creatinine level > 1.4 mg/dl drawn ≤30 days prior to study entry.
  • Severe, active co-morbitities.
  • Unstable angina, and/or congestive heart failure requiring hospitalization within the last 6 months.
  • Transmural myocardial infarction within the last 6 months
  • Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
  • Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects
  • Uncontrolled, clinically significant cardiac arrhythmias
  • Pregnancy

结局指标

主要结局

Alopecia

时间窗: 1 to 4 months after radiation

In this study the patient will receive either whole brain radiation therapy given by intensity modulated radiation therapy (IMRT) or standard conventional radiation. In IMRT therapy radiation dose to the parts of the brain that do not contain tumors is reduced.

次要结局

  • The study will also look at the effectiveness of both techniques in controlling the growth of the tumor.(1 year)
  • Quality of life(1 year after radiation)

研究者

发起方
Good Samaritan Hospital Medical Center, New York
申办方类型
Other
责任方
Principal Investigator
主要研究者

Johnny Kao

Principal Investigator

Good Samaritan Hospital Medical Center, New York

研究点 (2)

Loading locations...

相似试验

Phase II Trial of Conventional Versus IMRT Whole... | 临床试验